Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Eagle Pharmaceuticals Inc.

Eagle Pharmaceuticals Inc. (EGRX)

Market is closed
News

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Q2 2023 Earnings Call Transcript

Operator: Good morning, everyone. My name is Shelby and I will be your conference operator. At this time, I'd like to welcome everyone to Eagle Pharmaceuticals' Second Quarter 2023 Financial Results.

Keep Reading →

August 10th, 2023 - News Transcripts

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Q4 2022 Earnings Call Transcript

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Q4 2022 Earnings Call Transcript

Operator: Good morning, everyone. My name is Todd, and I'll be your conference operator.

Keep Reading →

March 14th, 2023 - News Transcripts

What Made Eagle Pharmaceuticals (EGRX) Stock to Decline in Q3?

What Made Eagle Pharmaceuticals (EGRX) Stock to Decline in Q3?

Scout Investments, an affiliate of Carillon Tower Advisers, an investment management company, released its “Carillon Scout Small Cap Fund” third quarter 2022 investor letter.

Keep Reading →

January 3rd, 2023 - Hedge Fund Investor Letters News

Were Hedge Funds Right About Eagle Pharmaceuticals Inc (EGRX)?

Were Hedge Funds Right About Eagle Pharmaceuticals Inc (EGRX)?

Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September.

Keep Reading →

July 29th, 2021 - Hedge Funds News

Here's Why Summers Value Partners Exited its Eagle Pharmaceuticals (EGRX) Position

Here's Why Summers Value Partners Exited its Eagle Pharmaceuticals (EGRX) Position

Summers Value Partners, an investment management firm, published its “Summers Value Fund LP” first quarter 2021 investor letter – a copy of which can be downloaded here.

Keep Reading →

April 22nd, 2021 - Hedge Fund Investor Letters News

Is EGRX A Good Stock To Buy Now?

Is EGRX A Good Stock To Buy Now?

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.

Keep Reading →

December 15th, 2020 - Hedge Funds News

Eagle Pharmaceuticals (EGRX) Has Fallen 26% in Last One Year, Underperforms Market

Eagle Pharmaceuticals (EGRX) Has Fallen 26% in Last One Year, Underperforms Market

If you are looking for the best ideas for your portfolio you may want to consider some of Del Principe O’Brien Financial Advisors top stock picks.

Keep Reading →

September 25th, 2020 - Hedge Fund Investor Letters News

Eagle Pharmaceuticals (EGRX) Has Fallen 38% in Last One Year, Underperforms Market

Eagle Pharmaceuticals (EGRX) Has Fallen 38% in Last One Year, Underperforms Market

If you are looking for the best ideas for your portfolio you may want to consider some of Summers Value Partners top stock picks.

Keep Reading →

September 9th, 2020 - Hedge Fund Investor Letters News

Hedge Funds Are Buying Eagle Pharmaceuticals Inc (EGRX)

Hedge Funds Are Buying Eagle Pharmaceuticals Inc (EGRX)

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter.

Keep Reading →

June 27th, 2020 - Hedge Funds News

Eagle Pharmaceuticals Inc (EGRX): Are Hedge Funds Right About This Stock?

Eagle Pharmaceuticals Inc (EGRX): Are Hedge Funds Right About This Stock?

We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.

Keep Reading →

December 11th, 2019 - Hedge Funds News

Insider Monkey Quarterly Strategy
+336.2% Insider Monkey Quarterly Strategy
+144.8% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)